Cresco Labs (CRLBF) Total Current Liabilities (2019 - 2026)

Cresco Labs has reported Total Current Liabilities for 8 years, with the latest figure at $98.2 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 13.27% year-over-year to $98.2 million; the trailing twelve-month figure through Mar 2026 stood at $98.2 million (down 13.27% YoY), and the FY2025 full-year result was $100.2 million, up 6.19% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $98.2 million, down from $100.2 million in the prior quarter.
• The five-year high for Total Current Liabilities was $331.2 million in Q1 2022, with the low at $94.3 million in Q4 2024.
• Historically, Total Current Liabilities has averaged $186.3 million across 5 years, with a median of $200.2 million in 2023.
• Annual changes were most pronounced in 2022 — Total Current Liabilities advanced 29.31% — and 2024, when it plunged 52.89%.
• Cresco Labs' Total Current Liabilities stood at $255.9 million in 2022, then fell by 21.74% to $200.2 million in 2023, then sank by 52.89% to $94.3 million in 2024, then climbed by 6.19% to $100.2 million in 2025, then slipped by 2.0% to $98.2 million in 2026.
• The last three Total Current Liabilities figures came in at $98.2 million (Q1 2026), $100.2 million (Q4 2025), and $97.4 million (Q3 2025), per Business Quant data.